Vakrangee is currently trading at Rs. 40.20, up by 1.55 points or 4.01% from its previous closing of Rs. 38.65 on the BSE.
The scrip opened at Rs. 39.80 and has touched a high and low of Rs. 40.65 and Rs. 39.30 respectively. So far 375887 shares were traded on the counter.
The BSE group ‘A’ stock of face value Rs. 1 has touched a 52 week high of Rs. 69.85 on 31-Dec-2020 and a 52 week low of Rs. 29.15 on 11-Aug-2021.
Last one week high and low of the scrip stood at Rs. 40.65 and Rs. 35.75 respectively. The current market cap of the company is Rs. 4094.60 crore.
The promoters holding in the company stood at 42.60%, while Institutions and Non-Institutions held 14.75% and 42.64% respectively.
Vakrangee’s 100% subsidiary — Vakrangee Digital Ventures has tied up with PharmEasy (Axelia Solutions) to provide online medicines and healthcare services to the unserved and underserved population of India.
Under this partnership, Vakrangee through its Nextgen Kendras and BharatEasy Mobile Superaap will now be able to provide medicines & healthcare services in remote areas of the country. With 70% of Nextgen Vakrangee Kendra outlets in Tier-5 and 6 towns, Vakrangee will offer medicines & healthcare services to the communities in the unserved/underserved parts of the country. The customers will also be able to avail various discount offers and get significant savings on their purchases of medicines and health products.
PharmEasy provides a wide range of prescription (medicines), OTC pharmaceutical, other consumer healthcare products, comprehensive diagnostic test services, and teleconsultations thereby serving the healthcare needs.
Vakrangee is the unique technology driven company focused on building India’s largest network of last mile retail outlets to deliver real time banking & Financial Services, ATM, insurance, e-governance, ecommerce and logistics services to the un-served rural, semi-urban and urban markets.